Across TCGA pan-cancer cohorts, RNU6-1139P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU6-1139P data layer.

The strongest signal is observed in acute myeloid leukemia (LAML), where higher RNU6-1139P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1139P expression acts as an unfavorable survival marker.

LAML and SARC are the cancer types where RNU6-1139P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LAML	DFS	Tertile	All	0.081	0.572	.003	36	view →
SARC	OS	Tertile	All	0.217	0.772	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNU6-1139P tumor-vs-normal RNA expression · all RNU6-1139P data types